Sanara MedTech (SMTI)
NASDAQ:SMTI
Want to see SMTI full AI Analyst Report?
Total Valuation
Sanara MedTech has a market cap or net worth of $200.60M. The enterprise value is $242.98M.
Market Cap$200.60M
Enterprise Value$242.98M
Share Statistics
Sanara MedTech has 9,163,969 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,163,969
Owned by Insiders3.28%
Owned by Institutions1.81%
Financial Efficiency
Sanara MedTech’s return on equity (ROE) is -6.33 and return on invested capital (ROIC) is 16.73%.
Return on Equity (ROE)-6.33
Return on Assets (ROA)-0.51
Return on Invested Capital (ROIC)16.73%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee731.33K
Profits Per Employee-196.14K
Employee Count141
Asset Turnover1.41
Inventory Turnover2.58
Valuation Ratios
The current PE Ratio of Sanara MedTech is 81.5. Sanara MedTech’s PEG ratio is -0.02.
PE Ratio81.5
PS Ratio1.95
PB Ratio33.96
Price to Fair Value33.96
Price to FCF93.17
Price to Operating Cash Flow31.30
PEG Ratio-0.02
Income Statement
In the last 12 months, Sanara MedTech had revenue of 103.12M and earned -37.56M in profits. Earnings per share was -4.36.
Revenue103.12M
Gross Profit92.94M
Operating Income9.15M
Pretax Income-393.12K
Net Income-37.56M
EBITDA11.81M
Earnings Per Share (EPS)-4.36
Cash Flow
In the last 12 months, operating cash flow was 6.32M and capital expenditures -2.95M, giving a free cash flow of 3.37M billion.
Operating Cash Flow6.32M
Free Cash Flow3.37M
Free Cash Flow per Share0.37
Dividends & Yields
Sanara MedTech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.39
52-Week Price Change-26.76%
50-Day Moving Average18.92
200-Day Moving Average24.30
Relative Strength Index (RSI)66.74
Average Volume (3m)61.65K
Important Dates
Sanara MedTech upcoming earnings date is Aug 17, 2026, Before Open (Confirmed).
Last Earnings DateMay 11, 2026
Next Earnings DateAug 17, 2026
Ex-Dividend Date―
Financial Position
Sanara MedTech as a current ratio of 1.80, with Debt / Equity ratio of 688.13%
Current Ratio1.80
Quick Ratio1.59
Debt to Market Cap0.23
Net Debt to EBITDA2.68
Interest Coverage Ratio1.35
Taxes
In the past 12 months, Sanara MedTech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sanara MedTech EV to EBITDA ratio is 19.73, with an EV/FCF ratio of 107.80.
EV to Sales2.26
EV to EBITDA19.73
EV to Free Cash Flow107.80
EV to Operating Cash Flow34.33
Balance Sheet
Sanara MedTech has $13.59M in cash and marketable securities with $48.37M in debt, giving a net cash position of -$34.77M billion.
Cash & Marketable Securities$13.59M
Total Debt$48.37M
Net Cash-$34.77M
Net Cash Per Share-$3.79
Tangible Book Value Per Share-$1.89
Margins
Gross margin is 91.19%, with operating margin of 8.87%, and net profit margin of -36.43%.
Gross Margin91.19%
Operating Margin8.87%
Pretax Margin-0.38%
Net Profit Margin-36.43%
EBITDA Margin11.45%
EBIT Margin8.87%
Analyst Forecast
The average price target for Sanara MedTech is $34.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$34.00
Price Target Upside15.18% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast17.41%
EPS Growth Forecast-189.91%